Garrett Enten

411 total citations
28 papers, 273 citations indexed

About

Garrett Enten is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Garrett Enten has authored 28 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Garrett Enten's work include Chemokine receptors and signaling (8 papers), Receptor Mechanisms and Signaling (7 papers) and Diabetic Foot Ulcer Assessment and Management (4 papers). Garrett Enten is often cited by papers focused on Chemokine receptors and signaling (8 papers), Receptor Mechanisms and Signaling (7 papers) and Diabetic Foot Ulcer Assessment and Management (4 papers). Garrett Enten collaborates with scholars based in United States, Italy and United Arab Emirates. Garrett Enten's co-authors include Enrico M. Camporesi, Devanand Mangar, Hesham R. Omar, Mehdi Mirsaeidi, Matthias Majetschak, Xianlong Gao, Anthony J. DeSantis, Gerardo Bosco, Sandro Malacrida and Alessandra Vezzoli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Garrett Enten

25 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garrett Enten United States 9 78 61 56 50 42 28 273
Aymeric Douillard France 9 34 0.4× 9 0.1× 66 1.2× 34 0.7× 21 0.5× 14 375
Sebastian Klein Austria 9 46 0.6× 20 0.3× 28 0.5× 11 0.2× 25 0.6× 30 357
Rongguo Yu China 11 92 1.2× 16 0.3× 44 0.8× 15 0.3× 32 0.8× 27 254
Benjamin W. Hoyt United States 10 179 2.3× 5 0.1× 41 0.7× 16 0.3× 13 0.3× 44 335
Mark Tenholder United States 8 251 3.2× 25 0.4× 68 1.2× 36 0.7× 5 0.1× 9 386
Puneet Gupta United States 12 202 2.6× 18 0.3× 39 0.7× 13 0.3× 34 0.8× 69 346
A. Furlong United Kingdom 7 458 5.9× 68 1.1× 43 0.8× 59 1.2× 32 0.8× 7 643
Ferdinando Latteri Italy 12 140 1.8× 26 0.4× 41 0.7× 143 2.9× 19 0.5× 19 423
Yuka Uchiyama Japan 12 58 0.7× 39 0.6× 60 1.1× 6 0.1× 22 0.5× 41 367
Shaoyong Wu China 8 74 0.9× 43 0.7× 47 0.8× 19 0.5× 16 338

Countries citing papers authored by Garrett Enten

Since Specialization
Citations

This map shows the geographic impact of Garrett Enten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garrett Enten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garrett Enten more than expected).

Fields of papers citing papers by Garrett Enten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garrett Enten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garrett Enten. The network helps show where Garrett Enten may publish in the future.

Co-authorship network of co-authors of Garrett Enten

This figure shows the co-authorship network connecting the top 25 collaborators of Garrett Enten. A scholar is included among the top collaborators of Garrett Enten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garrett Enten. Garrett Enten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Enten, Garrett, et al.. (2024). Ethanol promotes protease activated receptor 1: Chemokine (C-X-C motif) receptor 4 heteromerization and enhances thrombin-induced impairment of human lung endothelial cell barrier function. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167335–167335.
2.
Enten, Garrett, et al.. (2024). Chemokine receptor hetero-oligomers regulate monocyte chemotaxis. Life Science Alliance. 7(8). e202402657–e202402657. 2 indexed citations
3.
Gao, Xianlong, et al.. (2023). α1-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α1B/D-adrenoceptors via interference with heteromer formation. Pharmacological Research. 190. 106730–106730. 2 indexed citations
4.
DeSantis, Anthony J., et al.. (2023). Effects of chemokine (C-C motif) receptor 2 and 3 antagonists in rat models of hemorrhagic shock. PLoS ONE. 18(4). e0284472–e0284472.
5.
DeSantis, Anthony J., Garrett Enten, Xianlong Gao, & Matthias Majetschak. (2021). Chemokine receptor antagonists with α 1 -adrenergic receptor blocker activity. Journal of Basic and Clinical Physiology and Pharmacology. 33(4). 519–523. 2 indexed citations
6.
Gao, Xianlong, Garrett Enten, Anthony J. DeSantis, & Matthias Majetschak. (2021). Class A G protein‐coupled receptors assemble into functional higher‐order hetero‐oligomers. FEBS Letters. 595(14). 1863–1875. 8 indexed citations
7.
Paganini, Matteo, Gerardo Bosco, Garrett Enten, et al.. (2021). Quality Improvement Project of a Massive Transfusion Protocol (MTP) to Reduce Wastage of Blood Components. International Journal of Environmental Research and Public Health. 18(1). 274–274. 5 indexed citations
8.
Liang, Xiaomei, Garrett Enten, Anthony J. DeSantis, et al.. (2020). Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia–reperfusion injury and hemorrhage. Scientific Reports. 10(1). 11359–11359. 6 indexed citations
9.
Gao, Xianlong, Garrett Enten, Anthony J. DeSantis, et al.. (2020). Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays. Biochemical and Biophysical Research Communications. 528(2). 368–375. 12 indexed citations
10.
Gao, Xianlong, You-Hong Cheng, Garrett Enten, et al.. (2020). Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. Journal of Biological Chemistry. 295(44). 14893–14905. 13 indexed citations
11.
12.
Enten, Garrett, et al.. (2019). Sugammadex administration shortens reversal times but not operating room turnover times. 5(1). 27–27. 3 indexed citations
13.
Rizzato, Alex, et al.. (2018). Effect of mild hyperbaric oxygen therapy on children diagnosed with autism. Undersea and Hyperbaric Medicine. 45(6). 639–644. 2 indexed citations
14.
Bosco, Gerardo, et al.. (2018). Femoral condylar necrosis: treatment with hyperbaric oxygen therapy. Arthroplasty Today. 4(4). 510–515. 7 indexed citations
15.
Enten, Garrett, et al.. (2018). Human Botfly: A Case Report and Overview of Differential Diagnosis. Journal of Investigative Medicine High Impact Case Reports. 6. 2735266844–2735266844. 10 indexed citations
16.
Bosco, Gerardo, Simona Mrakic‐Sposta, Alex Rizzato, et al.. (2018). Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. Journal of Enzyme Inhibition and Medicinal Chemistry. 33(1). 1501–1505. 58 indexed citations
17.
Camporesi, Enrico M., et al.. (2017). Review on hyperbaric oxygen treatment in femoral head necrosis. Undersea and Hyperbaric Medicine. 44(6). 497–508. 10 indexed citations
18.
Omar, Hesham R., et al.. (2017). Syncope on presentation is a surrogate for submassive and massive acute pulmonary embolism. The American Journal of Emergency Medicine. 36(2). 297–300. 10 indexed citations
19.
Omar, Hesham R., et al.. (2015). Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery. Drugs in R&D. 15(2). 187–194. 8 indexed citations
20.
Omar, Hesham R., et al.. (2015). Incidence and predictors of ischemic cerebrovascular stroke among patients on extracorporeal membrane oxygenation support. Journal of Critical Care. 32. 48–51. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026